Zota Health Care Ltd. · NSE:ZOTA
Zota Health Care — Q1 FY2022 Earnings Presentation
27 slides from Zota Health Care's earnings presentation, Aug 2, 2021
Slide 1: Investor Presentation cover letter to NSE
A Zota healthcare Itd. August 02, 2021 To, The Manager Listing Department, The National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai -400051 Dear Sir/Madam, Trading Symbol: ZOTA Sub: Investor Presentation Ref: Regulation 30 of SEBI (Listing Obligations and
Slide 2: Q1FY22 Performance Highlights
Q1FY22 PERFORMANCE HIGHLIGHTS JULY 2021
Slide 3: Safe Harbour
Safe Harbour This presentation has been prepared by the Zota Health Care Limited (the “Company”) only for information purpose to the stakeholders and does not contain any offer or invitation to subscribe the securities of the Company. No offering of securities shall be made except by means of offer
Slide 4: Table Of Contents
Table Of Contents 01 RESULT HIGHLIGHTS 02 OPERATIONAL METRICS 03 DAVAINDIA BUSINESS OUTLOOK 04 & STRATEGY 05 FINANCIAL SUMMARY zotahealthcare.com
Slide 5: Q1FY22 Result Highlights
Q1FY22- Result Highlights zotahealthcare.com
Slide 6: Standalone Quarterly Financial Highlights
Stand Quarterly Financial Highlights Q-o-Q Revenues (₹ Lakhs) Gross Profit (%) Operating Profit (₹ Lakhs) PAT (₹ Lakhs) Q1-FY22 34.02% Q1-FY22 488.62 Q1-FY22 337.41 Q1-FY22 3344.49 Q4-FY21 29.57% Q4-FY21 -14.24 Q4-FY21 -68.06 Q4-FY21 3064.26 Y-o-Y Revenues (₹ Lakhs) Gross Profit (%) Operating Profit
Slide 7: Revenue Break up – Quarterly
Revenue Break up – Quarterly Domestic Sales Dava India Sales Export Sales (SEZ) 1,815.1 896.8 1,013.4 768.7 1,282.2 1,056.2 632.6 370.0 328.7 Q1-FY21 Q4-FY21 Q1-FY22 Q1-FY21 Q4-FY21 Q1-FY22 Q1-FY21 Q4-FY21 Q1-FY22 06 zotahealthcare.com
Slide 8: FY Result Highlights
FY- Result Highlights zotahealthcare.com
Slide 9: Standalone Profit & Loss Statement - Quarterly
Stand Profit & Loss Statement - Quarterly Particulars (Rs Lakhs) Q1FY22 Q1FY21 YoY % QoQ % Q4FY21 Export Sales (SEZ) 632.6 328.7 92% -38% 1013.4 Dava India Sales 896.8 370.0 142% 17% 768.7 Domestic Sales 1,815.1 1,056.2 72% 42% 1,282.20 Revenues from Operations 3,344.5 1,754.96 91% 9% 3,064.26 Cost
Slide 10: Management Commentary
Management Commentary 01 Davaindia recorded best ever 02 Exports performance was 03 The sales contribution from quarterly Revenues in Q1FY22, disturbed in Q1FY22 despite new-age business stood at despite a challenging external good order book. This was 46% in Q1FY22 as compared environment. primaril
Slide 11: Management Commentary
Management Commentary DOMESTIC OPERATIONS Domestic Revenues EBITDA at ₹ 428.86 PAT stood at ₹ registered a growth of 90.14% Lakhs for Q1FY22, 286.44 Lakhs for YoY and 32.23% QoQ at ₹ backed by strong Q1FY22. 2711.9 Lakhs, supported by a recovery in demand surge in demand due to of Prescription Based
Slide 12: Davaindia Generic Pharmacy
Davaindia Generic Pharmacy zotahealthcare.com
Slide 13: Davaindia Key Figures: Stores and SKUs
zotahealthcare.com 49 Q1-FY22 100 Q4-FY21 109 Q3-FY21 99 Q2-FY21 31 Q1-FY21 Stores rolled-out 32 Q4-FY20 45 Q3-FY20 Davaindia Key Figures 33 Q2-FY20 39 Q1-FY20 1,503 Q1-FY22 1,431 Q4-FY21 1,371 Q3-FY21 1,368 Q2-FY21 1,353 Q1-FY21 1,338 Q4-FY20 1,333 Q3-FY20 1,310 Q2-FY20 SKU’s 1,250 Q1-FY20 012
Slide 14: Davaindia Key Figures: Customers and Wallet Spend
zotahealthcare.com 4,73,181 Q1-FY22 4,40,458 Q4-FY21 No. of Customers Served 3,23,395 Q3-FY21 3,52,623 Q2-FY21 3,38,415 Q1-FY21 2,75,520 Q4-FY20 2,67,030 Q3-FY20 Davaindia Key Figures 2,59,022 Q2-FY20 2,21,975 Q1-FY20 220 Q1-FY22 204 Q4-FY21 209 Q3-FY21 Average Wallet Spend 181 Q2-FY21 164 Q1-FY21 1
Slide 15: Davaindia - Generic Pharmacy
Davaindia- Generic Pharmacy During the quarter Davaindia has Davaindia has led the revolution of Davaindia retail pharmacy stores’ catered to 4.73 lakhs customers patients opting for generic medicines focus continues to be chronic ailments against 4.40 lakhs in Q4FY21, coupled against branded counte
Slide 16: Davaindia - Generic Pharmacy
Davaindia- Generic Pharmacy 15 zotahealthcare.com
Slide 17: Davaindia - COCO Stores
Davaindia- COCO Stores 16 zotahealthcare.com
Slide 18: Davaindia Footprints
Davaindia Footprints 640 States Assam Bihar No. of Stores 04 07 TOTAL NUMBER OF STORES Chattisgarh 05 Goa 01 Gujarat 139 Haryana 27 Himachal Pradesh 03 Jharkhand 09 Karnataka 08 Kashmir 02 Kerala 13 Madhya Pradesh 88 Maharashtra 111 Meghalaya 01 New Delhi 45 Odisha 31 Punjab 09 Rajasthan 24 Tamil Na
Slide 19: Management Commentary
Management Commentary Commenting on Q1FY22 financial performance and operational highlights, Management Team of Zota Health Care said, “We are happy to report a great set of numbers in a rather challenging quarter. In Q1FY22, Davaindia and the domestic Marketing business led the charge, with a surge
Slide 20: Industry Snapshot & Business Strategy
Industry Snapshot & Business Strategy zotahealthcare.com
Slide 21: Retail Generic Medicine Landscape in India
Retail Generic Medicine Landscape in India To achieve the objective of making available quality generic medicines at affordable prices to all, ‘Jan Aushadhi Scheme’ was launched by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India across the county. The sche
Slide 22: Impact of PMBJP
Impact of PMBJP In the financial year (2019-20), PMBJP has achieved sales of ₹258 crores (at MRP), up to 30-11-2019. This has led to savings of approximately ₹1,800 crores of the common citizens of the country. Growth in number of stores Growth in turnover Product basket Price of Janaushadhi medicin
Slide 23: Underpenetrated Generic Medicine Market
Underpenetrated Generic Medicine Market 4 pillars to drive Branded and generic mix of Indian healthcare pharma market (%) Overall India Urban India Rural India 4 As of healthcare 8 6 15 1 Accessibility 2 Affordability 3 Awarness 4 Aliments 92 94 85 • Setting up of new • Higher per capita • Rising li
Slide 24: Financial Summary
Financial Summary zotahealthcare.com
Slide 25: Profit & Loss Statement
Profit & Loss Statement Particulars (INR Lakhs) FY15 FY16 FY17 FY18 FY19 FY20 FY21 Income from Operations 5,646.3 6,473.3 7,158.0 7,785.2 8,562.9 9,511.3 10678.92 Other Income 1.4 7.7 5.6 151.9 154.5 151.3 125.97 Total Income 5,647.8 6,481.0 7,163.6 7,937.0 8,717.4 9,662.6 10804.89 Operating Expense
Slide 26: Balance Sheet & Key Ratios
Balance Sheet & Key Ratios Particulars (INR Lakhs) FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Share capital 1,196.9 1,436.3 1,436.3 1,436.3 1,754.3 1,754.3 2,456.0 2,456.0 Reserves and Surplus 384.2 395.7 707.8 1,262.0 5,223.4 5,138.2 4,426.9 4,173.6 Non-current liabilities 521.3 548.7 272.7 466.8 64.7
Slide 27: Thank You
Thank You Contact Information Mr. Himanshu Zota / Mr. Ashvin Variya "ZOTA HOUSE", 2/896, Hira Modi Street, Sagrampura, Surat-395 002(Gujarat) cszota@zotahealthcare.com www.zotahealthcare.com